HIV/AIDS Prevention

U.S. NIH overlooked problems in Uganda AIDS study, whistleblower says

Published in TB and Outbreaks Week, January 25th, 2005

A U.S.-funded study on an AIDS drug was so poorly conducted that it potentially put the lives of hundreds of mothers and babies in Uganda at risk, a government whistleblower said January 4, 2005.

Jonathan Fishbein, MD, said officials at the U.S. National Institutes of Health (NIH) overlooked problems with the way the study was conducted on the drug, nevirapine, which was being used to protect babies in Africa from HIV infection during birth.

Fishbein testified before a panel of scientists at the independent Institute of Medicine. The NIH, which maintains that the drug is safe in single doses, asked the institute to conduct the review.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2005-01-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry